Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-30 Option Award |
2025-04-01 9:07 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
32,022 | $0.89 | 35,537 (Direct) |
View |
| 2024-12-18 Option Award |
2024-12-20 5:06 pm |
N/A 2034-12-18 |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
420,000 | $0.071 | 420,000 (Direct) |
View |
| 2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
299,238 | $0.0919 | 351,510 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-11 5:56 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
37,272 | $0 | 52,272 (Direct) |
View |
| 2024-04-22 Option Award |
2024-04-24 5:00 pm |
2025-04-22 2027-04-22 |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
3,000 | $0 | 206,332 (Direct) |
View |
| 2023-12-01 Option Award |
2023-12-05 5:20 pm |
N/A 2033-11-30 |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
65,000 | $5.51 | 65,000 (Direct) |
View |
| 2023-09-22 Option Award |
2023-09-26 5:49 pm |
N/A 2028-10-22 |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
15,000 | $11.5 | 30,000 (Direct) |
View |
| 2023-09-22 Option Award |
2023-09-26 5:49 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director |
15,000 | $0 | 30,000 (Direct) |
View |